Hongsheng Capital
Beijing, Beijinghudson-capital.com
Overview
Hongsheng Capital is a venture capital firm founded in 2017 and based in Beijing, China. The firm invests in early-stage companies and focuses on sectors including technology, consumption, cultural tourism, urbanization, biotechnology, and manufacturing.
Portfolio Companies
3
Website
hudson-capital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Arnatar Therapeutics | Apr 2024 | Series A | Co-investor |
| Jiangsu Xinhua Semiconductor Technology Co., Ltd. | Jun 2023 | Series B | Co-investor |
| Xi'an Eswin Material Technology Co., Ltd. | Dec 2022 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.